Literature DB >> 26491062

Effects of Acute and Repeated Administration of Oxycodone and Naloxone-Precipitated Withdrawal on Intracranial Self-Stimulation in Rats.

Jason M Wiebelhaus1, D Matthew Walentiny1, Patrick M Beardsley2.   

Abstract

Incidence of prescription opioid abuse and overdose, often led by oxycodone, continues to increase, producing twice as many overdose deaths as heroin. Surprisingly, preclinical reports relevant to oxycodone's abuse-related effects are relatively sparse considering its history and patient usage. The goal of this study was to characterize dose- and time-dependent effects of acute and repeated oxycodone administration in a frequency-rate intracranial self-stimulation (ICSS) procedure, an assay often predictive of drug-related reinforcing effects, in male Sprague-Dawley rats. We hypothesized that oxycodone would produce a biphasic profile of rate-increasing and rate-decreasing effects maintained by ICSS similar to μ-opioid receptor agonists. Oxycodone (0.03, 0.3, 1, and 3 mg/kg, s.c.) produced dose- and time-dependent alterations on ICSS, with the predicted biphasic profile of rate-increasing effects at lower stimulation frequencies followed by rate-decreasing effects at higher frequencies. Peak effects were observed between 30 and 60 minutes, which were reversed by naloxone pretreatment (30 minutes). Tolerance to rate-decreasing effects was observed over a 5-day period when rats were treated with 1 mg/kg oxycodone twice a day. Subsequently, the dosing regimen was increased to 3 mg/kg twice a day over 10 days, although further marked tolerance did not develop. When then challenged with 10 mg/kg naloxone, a significant suppression below baseline levels of ICSS-maintained responding occurred indicative of dependence that recovered to baseline within 5 hours. The results of this study provide the first report of acute and chronic effects of oxycodone on responding maintained by ICSS presentation and the use of ICSS-maintained responding to characterize its tolerance and dependence effects.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26491062      PMCID: PMC4702076          DOI: 10.1124/jpet.115.228940

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  50 in total

1.  Adolescent intermittent ethanol exposure diminishes anhedonia during ethanol withdrawal in adulthood.

Authors:  Nathalie Boutros; Svetlana Semenova; Athina Markou
Journal:  Eur Neuropsychopharmacol       Date:  2014-02-04       Impact factor: 4.600

2.  Dramatic decreases in brain reward function during nicotine withdrawal.

Authors:  M P Epping-Jordan; S S Watkins; G F Koob; A Markou
Journal:  Nature       Date:  1998-05-07       Impact factor: 49.962

3.  Changes in response rates and reinforcement thresholds for intracranial self-stimulation during morphine withdrawal.

Authors:  G J Schaefer; R P Michael
Journal:  Pharmacol Biochem Behav       Date:  1986-12       Impact factor: 3.533

4.  The heritability of oxycodone reward and concomitant phenotypes in a LG/J × SM/J mouse advanced intercross line.

Authors:  Camron D Bryant; Michael A Guido; Loren A Kole; Riyan Cheng
Journal:  Addict Biol       Date:  2012-12-12       Impact factor: 4.280

5.  Effects of l-tetrahydropalmatine on locomotor sensitization to oxycodone in mice.

Authors:  Yan-li Liu; Jian-hui Liang; Ling-di Yan; Rui-bin Su; Chun-fu Wu; Ze-hui Gong
Journal:  Acta Pharmacol Sin       Date:  2005-05       Impact factor: 6.150

6.  Postcocaine anhedonia. An animal model of cocaine withdrawal.

Authors:  A Markou; G F Koob
Journal:  Neuropsychopharmacology       Date:  1991-01       Impact factor: 7.853

7.  Behavioral and neurochemical changes induced by oxycodone differ between adolescent and adult mice.

Authors:  Yong Zhang; Roberto Picetti; Eduardo R Butelman; Stefan D Schlussman; Ann Ho; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2008-09-10       Impact factor: 7.853

8.  Deficit in brain reward function and acute and protracted anxiety-like behavior after discontinuation of a chronic alcohol liquid diet in rats.

Authors:  Daria Rylkova; Hina P Shah; Elysia Small; Adrie W Bruijnzeel
Journal:  Psychopharmacology (Berl)       Date:  2008-12-02       Impact factor: 4.530

9.  Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeys.

Authors:  Patrick M Beardsley; Mario D Aceto; Charles D Cook; Edward R Bowman; Jennifer L Newman; Louis S Harris
Journal:  Exp Clin Psychopharmacol       Date:  2004-08       Impact factor: 3.157

10.  Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats.

Authors:  S Stevens Negus; Ember M Morrissey; Marisa Rosenberg; K Cheng; Kenner C Rice
Journal:  Psychopharmacology (Berl)       Date:  2010-01-26       Impact factor: 4.530

View more
  12 in total

1.  Oxycodone physical dependence and its oral self-administration in C57BL/6J mice.

Authors:  Rachel M Enga; Asti Jackson; M Imad Damaj; Patrick M Beardsley
Journal:  Eur J Pharmacol       Date:  2016-07-05       Impact factor: 4.432

Review 2.  Determinants of opioid abuse potential: Insights using intracranial self-stimulation.

Authors:  S Stevens Negus; Megan J Moerke
Journal:  Peptides       Date:  2018-11-01       Impact factor: 3.750

3.  Role of agonist efficacy in exposure-induced enhancement of mu opioid reward in rats.

Authors:  Megan J Moerke; S Stevens Negus
Journal:  Neuropharmacology       Date:  2019-03-14       Impact factor: 5.250

4.  Effects of repeated treatment with methcathinone, mephedrone, and fenfluramine on intracranial self-stimulation in rats.

Authors:  J A Suyama; M L Banks; S S Negus
Journal:  Psychopharmacology (Berl)       Date:  2018-09-19       Impact factor: 4.530

5.  Repeated Morphine Produces Sensitization to Reward and Tolerance to Antiallodynia in Male and Female Rats with Chemotherapy-Induced Neuropathy.

Authors:  L P Legakis; S S Negus
Journal:  J Pharmacol Exp Ther       Date:  2018-01-23       Impact factor: 4.030

6.  Naltrexone maintenance fails to alter amphetamine effects on intracranial self-stimulation in rats.

Authors:  Farhana Sakloth; S Stevens Negus
Journal:  Exp Clin Psychopharmacol       Date:  2018-03-12       Impact factor: 3.157

7.  The ups and downs of relating nondrug reward activation to substance use risk in adolescents.

Authors:  James M Bjork
Journal:  Curr Addict Rep       Date:  2020-08-07

8.  Temporal parameters of enhanced opioid reward after initial opioid exposure in rats.

Authors:  Megan J Moerke; S Stevens Negus
Journal:  Psychopharmacology (Berl)       Date:  2021-01-07       Impact factor: 4.530

9.  Paradoxical changes in brain reward status during oxycodone self-administration in a novel test of the negative reinforcement hypothesis.

Authors:  Jacques D Nguyen; Yanabel Grant; Michael A Taffe
Journal:  Br J Pharmacol       Date:  2021-06-08       Impact factor: 9.473

10.  BOLD Imaging in Awake Wild-Type and Mu-Opioid Receptor Knock-Out Mice Reveals On-Target Activation Maps in Response to Oxycodone.

Authors:  Kelsey Moore; Dan Madularu; Sade Iriah; Jason R Yee; Praveen Kulkarni; Emmanuel Darcq; Brigitte L Kieffer; Craig F Ferris
Journal:  Front Neurosci       Date:  2016-11-03       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.